{"id":"bupropion-nicotine-gum","safety":{"commonSideEffects":[{"rate":"30-40","effect":"Insomnia"},{"rate":"10-20","effect":"Dry mouth"},{"rate":"10-15","effect":"Nausea"},{"rate":"10-15","effect":"Headache"},{"rate":"5-10","effect":"Dizziness"},{"rate":"5-10","effect":"Jaw soreness (from gum)"},{"rate":"5","effect":"Hiccups"},{"rate":"0.4","effect":"Seizures (bupropion)"}]},"_chembl":{"chemblId":"CHEMBL1201735","moleculeType":"Small molecule","molecularWeight":"320.66"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Bupropion is an atypical antidepressant that increases dopamine and norepinephrine availability in the brain, reducing the reward deficit and withdrawal symptoms associated with nicotine cessation. Nicotine gum delivers nicotine transdermally through oral mucosa, satisfying nicotine dependence while allowing gradual dose reduction. The combination addresses both the neurochemical and behavioral components of tobacco addiction.","oneSentence":"Bupropion inhibits norepinephrine and dopamine reuptake to reduce cravings and withdrawal symptoms, while nicotine gum provides nicotine replacement therapy to satisfy addiction and support smoking cessation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:40:12.523Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Smoking cessation in adults with nicotine dependence"}]},"trialDetails":[{"nctId":"NCT04634071","phase":"PHASE2","title":"Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment","status":"COMPLETED","sponsor":"Joseph Valentino, MD","startDate":"2021-01-12","conditions":"Smoking Cessation, Cancer, Treatment-Related","enrollment":126},{"nctId":"NCT04490057","phase":"PHASE4","title":"A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV","status":"COMPLETED","sponsor":"Yale University","startDate":"2020-07-27","conditions":"Tobacco Use Cessation","enrollment":323},{"nctId":"NCT04604509","phase":"PHASE4","title":"Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-08-04","conditions":"Cigarette Smoking-Related Carcinoma","enrollment":2010},{"nctId":"NCT04694846","phase":"NA","title":"Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2020-08-19","conditions":"Lung Non-Small Cell Carcinoma, Head and Neck Squamous Cell Carcinoma","enrollment":19},{"nctId":"NCT03670316","phase":"PHASE4","title":"Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2020-08-17","conditions":"HIV, AIDS, Smoking Cessation","enrollment":378},{"nctId":"NCT04654585","phase":"NA","title":"Preference-based Tools for Smoking Cessation Among Disadvantaged Smokers, a Pragmatic Randomised Controlled Trial","status":"COMPLETED","sponsor":"Société de Formation Thérapeutique du Généraliste - Recherche","startDate":"2021-02-26","conditions":"Smoking, Smoking Cessation","enrollment":167},{"nctId":"NCT04717544","phase":"NA","title":"Embedding Comprehensive Smoking Cessation Programs Into Community Clinics","status":"COMPLETED","sponsor":"Friends Research Institute, Inc.","startDate":"2019-10-01","conditions":"Smoking Cessation","enrollment":406},{"nctId":"NCT04135937","phase":"PHASE4","title":"Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2019-11-18","conditions":"Human Immunodeficiency Virus, Smoking","enrollment":12},{"nctId":"NCT02245308","phase":"PHASE4","title":"Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2014-10-01","conditions":"Tobacco Use Disorder, Homelessness","enrollment":133},{"nctId":"NCT02050308","phase":"PHASE3","title":"Web-based Smoking Cessation Program for Tribal College Students","status":"COMPLETED","sponsor":"Won Choi, PhD, MPH","startDate":"2015-05","conditions":"Smoking Cessation","enrollment":251},{"nctId":"NCT02995915","phase":"PHASE4","title":"Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking","status":"COMPLETED","sponsor":"Duke University","startDate":"2016-11","conditions":"Smoking Cessation, Alcohol Drinking","enrollment":45},{"nctId":"NCT04501016","phase":"PHASE2, PHASE3","title":"A Stepped Care Approach to Treating Tobacco Use in Rural Veterans","status":"NOT_YET_RECRUITING","sponsor":"Iowa City Veterans Affairs Medical Center","startDate":"2020-09","conditions":"Tobacco Cessation","enrollment":100},{"nctId":"NCT02869451","phase":"NA","title":"Mobile Contingency Management for Marijuana and Tobacco Cessation","status":"COMPLETED","sponsor":"Duke University","startDate":"2016-08","conditions":"Cigarette Smoking, Marijuana Abuse","enrollment":7},{"nctId":"NCT01592695","phase":"PHASE2","title":"Tailored Tobacco Quitline for Rural Veterans","status":"COMPLETED","sponsor":"Iowa City Veterans Affairs Medical Center","startDate":"2012-06","conditions":"Cigarette Smoking","enrollment":63},{"nctId":"NCT02994082","phase":"NA","title":"Treating Smokeless Tobacco Use in Rural Veterans","status":"UNKNOWN","sponsor":"Mark Vander Weg","startDate":"2016-12","conditions":"Smokeless Tobacco, Nicotine Dependence","enrollment":123},{"nctId":"NCT02420015","phase":"PHASE4","title":"Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia","status":"COMPLETED","sponsor":"Duke University","startDate":"2017-03-27","conditions":"Schizophrenia, Cigarette Smoking","enrollment":35},{"nctId":"NCT02744417","phase":"NA","title":"Effect of Smoking Cessation on Clinical and Microbiological Outcomes of the Non-surgical Periodontal Therapy","status":"COMPLETED","sponsor":"Claudio Mendes Pannuti","startDate":"2010-08","conditions":"Periodontitis","enrollment":63},{"nctId":"NCT01901848","phase":"PHASE2, PHASE3","title":"CPT and Smoking Cessation","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2013-12-11","conditions":"Stress Disorders, Post-Traumatic, Smoking","enrollment":69},{"nctId":"NCT02873754","phase":"NA","title":"Smoking Treatment and Exercise Program for Underserved Populations (STEP UP)","status":"COMPLETED","sponsor":"Duke University","startDate":"2017-01","conditions":"Smoking","enrollment":11},{"nctId":"NCT01892813","phase":"PHASE3","title":"Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers","status":"UNKNOWN","sponsor":"Mark Vander Weg","startDate":"2013-07","conditions":"Nicotine Dependence, Tobacco Use","enrollment":411},{"nctId":"NCT00060814","phase":"PHASE2","title":"Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2002-06","conditions":"Tobacco Use Disorder","enrollment":28},{"nctId":"NCT00063323","phase":"PHASE3","title":"Maintenance Treatment for Abstinent Smokers","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2000-08","conditions":"Tobacco Use Disorder","enrollment":589},{"nctId":"NCT00307203","phase":"PHASE4","title":"Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"1998-08","conditions":"Tobacco-Use Disorder, Schizophrenia, Psychotic Disorders","enrollment":51},{"nctId":"NCT01621022","phase":"PHASE4","title":"Bupropion Alone or Combined With Nicotine Gum","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2001-01","conditions":"Tobacco Dependence","enrollment":608},{"nctId":"NCT00320697","phase":"PHASE4","title":"Smoking Relapse Prevention in Schizophrenia","status":"COMPLETED","sponsor":"North Suffolk Mental Health Association","startDate":"2006-04","conditions":"Schizophrenia, Schizoaffective Disorder, Smokers","enrollment":25},{"nctId":"NCT01990079","phase":"NA","title":"Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD","status":"COMPLETED","sponsor":"Duke University","startDate":"2013-12","conditions":"PTSD, Smoking","enrollment":15},{"nctId":"NCT01850589","phase":"NA","title":"Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice","status":"TERMINATED","sponsor":"Northwell Health","startDate":"2011-03","conditions":"Smoking Cessation","enrollment":44},{"nctId":"NCT01789710","phase":"NA","title":"Contingency Management for Smoking Cessation in Homeless Smokers","status":"COMPLETED","sponsor":"Duke University","startDate":"2013-01","conditions":"Smoking, Homeless Persons","enrollment":25},{"nctId":"NCT01576640","phase":"PHASE4","title":"Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2005-12","conditions":"Nicotine Dependence, Schizophrenia","enrollment":17},{"nctId":"NCT00086385","phase":"PHASE3","title":"Maintaining Nonsmoking: Older Smokers - 1","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2001-09","conditions":"Tobacco Use Disorder","enrollment":403},{"nctId":"NCT01309217","phase":"PHASE4","title":"Dissemination of Tobacco Tactics for Hospitalized Smokers","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2011-07","conditions":"Smoking Cessation","enrollment":1528},{"nctId":"NCT00818207","phase":"PHASE4","title":"Impact Of Smoking Cessation Treatment Reimbursement On The Quit Rates In Smokers Motivated To Quit","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-03","conditions":"Smoking Cessation, Insurance Coverage","enrollment":1380},{"nctId":"NCT00125905","phase":"NA","title":"ISTAPS: A Stepped Primary Care Smoking Cessation Intervention","status":"UNKNOWN","sponsor":"Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina","startDate":"2003-10","conditions":"Smoking Cessation","enrollment":3012}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":98,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"bupropion + nicotine gum","genericName":"bupropion + nicotine gum","companyName":"University of Wisconsin, Madison","companyId":"university-of-wisconsin-madison","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bupropion inhibits norepinephrine and dopamine reuptake to reduce cravings and withdrawal symptoms, while nicotine gum provides nicotine replacement therapy to satisfy addiction and support smoking cessation. Used for Smoking cessation in adults with nicotine dependence.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}